Jane Street
IFRX icon

Jane Street’s InflaRx IFRX Stock Holding History

Jane Street’s Portfolio IFRX Stock Details IFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30K Buy
+13,400
New +$25.2K ﹤0.01% 11100
2026
Q1 		– Sell
-13,500
Closed -$13.6K – 12215
2025
Q4 		$13.6K Buy
+13,500
New +$16.8K ﹤0.01% 10791

Other funds holding IFRX

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return

Jane Street's IFRX Position: Q2 2026 in Review

Jane Street opened a new position in InflaRx (IFRX) in Q2 2026: 143,226 shares worth $321K. The stake represents ﹤0.01% of the portfolio and ranks #9062 among its holdings. This is a return to the name: Jane Street previously reported a position in IFRX as recently as Q4 2025.

Jane Street first reported a position in IFRX in Q3 2018 and has held it in 6 quarters since. 62 funds tracked by Wall St. Rank hold IFRX as of Q2 2026.

  • Jane Street held 143,226 shares of InflaRx worth $321K as of Q2 2026.
  • InflaRx was a new Jane Street position in Q2 2026.
  • InflaRx made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #9062 holding.
  • Jane Street first reported a position in InflaRx in Q3 2018 and has held it in 6 quarters since.
  • 62 funds tracked by Wall St. Rank held InflaRx as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.